EndocrinologyNews.net

Endocrinology Xagena

Search results for "Nexavar"

Sorafenib ( Nexavar ) holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which was presented during the American Societ ...